Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
IDP-004
- Development stage
- Preclinical
- Lead developer
- InduPro
- Modality
- Bispecific Antibodies → Multispecific Antibodies → Engineered Antibody Formats → Antibody-Based Therapeutics, Cytotoxic ADCs → Antibody-Drug Conjugates (ADCs) → Antibody Conjugates → Antibody-Based Therapeutics
- Administration
- Intravenous
01
Overview
IDP-004 is a bispecific antibody-drug conjugate (ADC) being developed by InduPro Therapeutics for the treatment of solid tumors. It is designed to simultaneously target MET (Hepatocyte Growth Factor Receptor) and a proprietary Tumor Associated Proximity Antigen-M1 (TAPA-M1). By leveraging InduPro's proximity biology platform, the drug aims to deliver a cytotoxic payload specifically to cancer cells where these two antigens are in close proximity, potentially improving the therapeutic index and overcoming resistance mechanisms associated with MET-targeted therapies. The drug is currently in the lead optimization stage of preclinical development.
02
Targets
MET (Mesenchymal-epithelial transition factor receptor)TAPA-M1 (Tumor associated proximity Antigen-M1)
Beyond the preview
Go deeper on IDP-004.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on IDP-004.